PDP1 and obesity disorder: Impaired PDH activity and reduced TCA cycle flux in skeletal muscle have been associated with obesity and type II diabetes as skeletal muscle is the primary site of systemic release of non-oxidized glycolytic products (lactate, pyruvate, alanine), which are biomarkers of chronic metabolic disease [48,49].